The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
UCHL1 is a Parkinson's disease susceptibility gene
Open accessAbstract
An Erratum has been published for this article in Ann Neurol 2004;55:899. The reported inverse association between the S18Y variant of the ubiquitin carboxy‐terminal hydrolase L1 (UCHL1) gene and Parkinson's disease (PD) has strong biological plausibility. If confirmed, genetic association of this variant with PD may support molecular targeting of the UCHL1 gene and its product as a therapeutic strategy for PD. In this light, we performed a collaborative pooled analysis of individual‐level data from all 11 published studies of the UCHL1 S18Y gene variant and PD. There were 1,970 cases and 2,224 unrelated controls. We found a statistically significant inverse association of S18Y with PD. Carriers of the variant allele (Y/Y plus Y/S vs S/S) had an odds ratio (OR) of 0.84 (95% confidence interval [CI], 0.73–0.95) and homozygotes for the variant allele (Y/Y vs S/S plus Y/S) had an OR of 0.71 (95% CI, 0.57–0.88). There was a linear trend in the log OR consistent with a gene dose effect (p = 0.01). The inverse association was most apparent for young cases compared with young controls. There was no evidence for publication bias and the associations remained significant after excluding the first published, hypothesis‐generating study. These findings confirm that UCHL1 is a susceptibility gene for PD and a potential target for disease‐modifying therapies. Ann Neurol 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Purcell, S., Cherny, S. S., & Sham, P. C. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.1.149 · Cited by 2,057
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
Self-citationThe ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Self-citationAssociation study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291 · cited 1×
“Third, in an effort to reduce the confounding effects of publication bias, our collaborative pooled analysis included one study that was published as an abstract only(11) and included unpublished data from the participating sites, whenever possible.(31) We also formally tested our series of studies for evidence of a p…”
MethodGeneralized linear mixed models a pseudo-likelihood approach
Wolfinger, R., & O'connell, M. (1993) · Journal of Statistical Computation and Simulation · doi:10.1080/00949659308811554 · Cited by 1,271
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 785
Genetic associations in large versus small studies: an empirical assessment
Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E., & Contopoulos-Ioannidis, D. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12516-0 · Cited by 579
Self-citationMeta-analysis of Observational Studies in Epidemiology
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000) · Cited by 473
Model-Free Analysis and Permutation Tests for Allelic Associations
Zhao, J. H., Curtis, D., & Sham, P. C. (2000) · Human Heredity · doi:10.1159/000022901 · Cited by 417
Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture.
Knowler, W. C., Williams, R. C., Pettitt, D. J., & Steinberg, A. G. (1988) · Europe PMC (PubMed Central) · Cited by 378
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
Little, J., Bradley, L., Bray, M. S., Clyne, M., Dorman, J., Ellsworth, D. L., Hanson, J., Khoury, M., Lau, J., O'Brien, T. R., et al. (2002) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a000179 · Cited by 370
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
Meta-analyses of molecular association studies: Methodologic lessons for genetic epidemiology
Attia, J. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00011-8 · Cited by 311
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
(1999) · Nature Genetics · doi:10.1038/8702 · Cited by 264
Parameters for reliable results in genetic association studies in common disease
Dahlman, I., Eaves, I. A., Kosoy, R., Morrison, V. A., Heward, J., Gough, S. C. L., Allahabadia, A., Franklyn, J. A., Tuomilehto, J., Tuomilehto-Wolf, E., et al. (2002) · Nature Genetics · doi:10.1038/ng825 · Cited by 229
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
Friedman, J. H., & Factor, S. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2<201::aid-mds1001>3.0.co;2-d · Cited by 214
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease
Maraganore, D. M., Farrer, M. J., Hardy, J. A., Lincoln, S. J., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.53.8.1858 · Cited by 209
Self-citationProteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
McNaught, K. S. P., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10512 · Cited by 203
Momose, Y., Murata, M., Kobayashi, K., Tachikawa, M., Nakabayashi, Y., Kanazawa, I., & Toda, T. (2002) · Annals of Neurology · doi:10.1002/ana.10079 · Cited by 198
Self-citationEvolution of treatment effects over time: Empirical insight from recursive cumulative metaanalyses
Ioannidis, J. P. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021529998 · Cited by 192
Self-citationWeale, M. E., Depondt, C., Macdonald, S. J., Smith, A., Lai, P. S., Shorvon, S. D., Wood, N. W., & Goldstein, D. B. (2003) · The American Journal of Human Genetics · doi:10.1086/378098 · Cited by 187
Goldstein, D. B., Ahmadi, K. R., Weale, M. E., & Wood, N. W. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.006 · Cited by 162
Mutation analysis and association studies of the UCHL1 gene in German Parkinsonʼs disease patients
Wintermeyer, P., Krüger, R., Kuhn, W., Müller, T. H., Woitalla, D., Berg, D., Becker, G., Leroy, E., Polymeropoulos, M. H., Berger, K., et al. (2000) · Neuroreport · doi:10.1097/00001756-200007140-00004 · Cited by 141
Self-citationCommentary: Meta-analysis of Individual Participants' Data in Genetic Epidemiology
Ioannidis, J. P. A., Rosenberg, P. S., Goedert, J. J., & O'Brien, T. R. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf031 · Cited by 117
Self-citationLincoln, S., Vaughan, J. R., Wood, N., Baker, M. C., Adamson, J. L., Gwinn, K. A., Lynch, T., Hardy, J., & Farrer, M. J. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00040 · Cited by 115
A common origin for cornified envelope proteins?
Backendorf, C., & Hohl, D. (1992) · Nature Genetics · doi:10.1038/ng1092-91 · Cited by 107
Satoh, J., & Kuroda, Y. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00555-x · Cited by 91
Self-citationElbaz, A., Lévecque, C., Clavel, J., Vidal, J., Richard, F., Corrèze, J., Delemotte, B., Amouyel, P., Alpérovitch, A., Chartier‐Harlin, M., et al. (2002) · Movement Disorders · doi:10.1002/mds.10326 · Cited by 76
Self-citationZhang, J., Hattori, N., Leroy, E., Morris, H. R., Kubo, S., Kobayashi, T., Wood, N. W., Polymeropoulos, M. H., & Mizuno, Y. (2000) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00015-8 · Cited by 68
Self-citationThe Human Genome Project Is Complete. How Do We Develop a Handle for the Pump?
Little, J., Khoury, M. J., Bradley, L., Clyne, M., Gwinn, M., Lin, B., Lindegren, M.-L., & Yoon, P. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg048 · Cited by 66
ACT and UCH‐L1 polymorphisms in Parkinson's disease and age of onset
Wang, J., Zhao, C., Si, Y.-M., Liu, Z., Chen, B., & Yu, L. (2002) · Movement Disorders · doi:10.1002/mds.10179 · Cited by 52
Self-citationLévecque, C., Destée, A., Mouroux, V., et al. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170017 · Cited by 44
Healy, D. G., Abou‐Sleiman, P. M., Ahmadi, K. R., Muqit, M. M. K., Bhatia, K. P., Quinn, N. P., Lees, A. J., Latchmann, D. S., Goldstein, D. B., & Wood, N. W. (2004) · Annals of Neurology · doi:10.1002/ana.20206 · Cited by 42
Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease
Li, Y., Hollingworth, P., Moore, P. J., Foy, C., Archer, N. J., Powell, J. F., Nowotny, P., Holmans, P., O’Donovan, M. C., Tacey, K. M., et al. (2005) · Human Mutation · doi:10.1002/humu.20138 · Cited by 38
Linkage exclusion in French families with probable Parkinson's disease
Farrer, M. J., Dest�e, A., Becquet, E., Vri�ze, F. W.-D., Mouroux, V., Richard, F., Defebvre, L., Lincoln, S., Hardy, J., Amouyel, P., et al. (2000) · Movement Disorders · doi:10.1002/1531-8257(200011)15:6<1075::aid-mds1004>3.0.co;2-2 · Cited by 34
Self-citationComplex interactions in Parkinson's disease: A two‐phased approach
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Farrer, M. J., Bower, J. H., Hardy, J., & Rocca, W. A. (2003) · Movement Disorders · doi:10.1002/mds.10431 · Cited by 33
Self-citationSolano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Cited by
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Genetics of Parkinson disease: paradigm shifts and future prospects
Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 707
The genetic epidemiology of neurodegenerative disease
Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 650
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Metadata
- Authors
- Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., Toda, T., Wang, J., Ioannidis, J. P. A., de Andrade, M., Rocca, W. A., & the UCHL1 Global Genetics Consortium
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-03-21
- Volume
- 55
- Issue
- 4
- Pages
- 512-521
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2129676131
- Cited by
- 262
- References
- 45
- FWCI
- 15.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.